Government and pharma ‘waiting for AMR crisis to escalate’
Efforts to combat antimicrobial resistance are lacking a ‘firm commitment of monies’, a report concludes.
Archives for October 9, 2019
Right to Try programs to ‘significantly accelerate' drug development: Beacon of Hope CRO
Beacon of Hope CRO is working with sponsors and other service providers to design Right to Try treatment programs, which the company’s founder says have ‘unmatched’ flexibility, an ability to treat screen fails and create ‘interim clinical milestones,’...
AstraZeneca earns FDA nod for at-home autoinjector
US FDA approves AstraZeneca’s at-home autoinjector for administration of an add-on treatment for severe asthma, matching the indication of GSK’s rival product, Nucala.